资讯

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...
Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The ...
Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...
Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.
Semaglutide, a GLP-1 receptor agonist sold under brand names Wegovy and Ozempic, is approved for weight loss and blood sugar ...
People with celiac disease had no problems after kissing a partner who'd just eaten a stack of saltine crackers, according to ...
Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the journal Nutrients ...
Weight-loss surgeries for adolescents increased 15% in the U.S. between 2021 and 2023, even as the Food and Drug ...
Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...